Is Fresenius Medical Stock a Good Investment?
Fresenius Medical Investment Advice | FMS |
- Examine Fresenius Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Fresenius Medical's leadership team and their track record. Good management can help Fresenius Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Fresenius Medical's business and its evolving consumer preferences.
- Compare Fresenius Medical's performance and market position to its competitors. Analyze how Fresenius Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Fresenius Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Fresenius Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Fresenius Medical Care stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Fresenius Medical Care is a good investment.
Sell | Buy |
Buy
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Fresenius Medical Stock
Researching Fresenius Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.49. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012.
Evaluating the company's potential for future growth is also very important to determine if Fresenius Medical is a good investment. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business.
Fresenius Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Fresenius Medical Care. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Fresenius Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Fresenius Medical's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 14.35 B.Fresenius Medical's profitablity analysis
The company has Net Profit Margin of 0.03 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.08 %, which entails that for every 100 dollars of revenue, it generated $0.08 of operating income.Determining Fresenius Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Fresenius Medical is a good buy. For example, gross profit margin measures Fresenius Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Fresenius Medical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Fresenius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fresenius Medical Care. Check Fresenius Medical's Beneish M Score to see the likelihood of Fresenius Medical's management manipulating its earnings.
Basic technical analysis of Fresenius Stock
As of the 27th of March, Fresenius Medical shows the Coefficient Of Variation of 1455.13, downside deviation of 1.72, and Mean Deviation of 1.15. Fresenius Medical Care technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fresenius Medical Care variance, as well as the relationship between the value at risk and skewness to decide if Fresenius Medical Care is priced favorably, providing market reflects its regular price of 24.26 per share. Given that Fresenius Medical has jensen alpha of 0.101, we urge you to verify Fresenius Medical Care's prevailing market performance to make sure the company can sustain itself at a future point.Fresenius Medical's Outstanding Corporate Bonds
Fresenius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fresenius Medical Care uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fresenius bonds can be classified according to their maturity, which is the date when Fresenius Medical Care has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
| FMEGR 375 15 JUN 29 Corp BondUS35805BAA61 | View | |
| FMEGR 2375 16 FEB 31 Corp BondUS35805BAB45 | View | |
| FMEGR 1875 01 DEC 26 Corp BondUS35805BAC28 | View | |
| FMEGR 3 01 DEC 31 Corp BondUS35805BAE83 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Fresenius Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Fresenius Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0627 | |||
| Market Risk Adjusted Performance | 0.1412 | |||
| Mean Deviation | 1.15 | |||
| Semi Deviation | 1.55 | |||
| Downside Deviation | 1.72 | |||
| Coefficient Of Variation | 1455.13 | |||
| Standard Deviation | 1.59 | |||
| Variance | 2.52 | |||
| Information Ratio | 0.064 | |||
| Jensen Alpha | 0.101 | |||
| Total Risk Alpha | 0.1038 | |||
| Sortino Ratio | 0.059 | |||
| Treynor Ratio | 0.1312 | |||
| Maximum Drawdown | 8.79 | |||
| Value At Risk | (2.73) | |||
| Potential Upside | 2.53 | |||
| Downside Variance | 2.97 | |||
| Semi Variance | 2.41 | |||
| Expected Short fall | (1.14) | |||
| Skewness | 0.0808 | |||
| Kurtosis | 1.41 |
| Risk Adjusted Performance | 0.0627 | |||
| Market Risk Adjusted Performance | 0.1412 | |||
| Mean Deviation | 1.15 | |||
| Semi Deviation | 1.55 | |||
| Downside Deviation | 1.72 | |||
| Coefficient Of Variation | 1455.13 | |||
| Standard Deviation | 1.59 | |||
| Variance | 2.52 | |||
| Information Ratio | 0.064 | |||
| Jensen Alpha | 0.101 | |||
| Total Risk Alpha | 0.1038 | |||
| Sortino Ratio | 0.059 | |||
| Treynor Ratio | 0.1312 | |||
| Maximum Drawdown | 8.79 | |||
| Value At Risk | (2.73) | |||
| Potential Upside | 2.53 | |||
| Downside Variance | 2.97 | |||
| Semi Variance | 2.41 | |||
| Expected Short fall | (1.14) | |||
| Skewness | 0.0808 | |||
| Kurtosis | 1.41 |
Consider Fresenius Medical's intraday indicators
Fresenius Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Fresenius Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Fresenius Medical time-series forecasting models is one of many Fresenius Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fresenius Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Fresenius Stock media impact
Far too much social signal, news, headlines, and media speculation about Fresenius Medical that are available to investors today. That information is available publicly through Fresenius media outlets and privately through word of mouth or via Fresenius internal channels. However, regardless of the origin, that massive amount of Fresenius data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fresenius Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fresenius Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fresenius Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fresenius Medical alpha.
Fresenius Medical Corporate Management
| Charlotte Stange | VP Sustainability | Profile | |
| Roberto Fuste | Member of the Management Board for Asia-Pacific | Profile | |
| Pascale Witz | Independent Member of the Supervisory Board | Profile | |
| GailSuzanne Brown | Senior Development | Profile | |
| Katarzyna MazurHofsab | Management AG | Profile | |
| Borries Muller | Senior Communications | Profile |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.